The global human papillomavirus vaccine market is anticipated to grow at a significant CAGR of 7.1% during the forecast period. The major drivers attributed to the growth of the market are rising awareness among people regarding the human papillomavirus vaccine. With the rise in the cases of cervical cancer every year, the HPV vaccination is increasing, which is aiding in the growth of the market. Additionally, the government initiatives and programs to provide vaccines to people are supporting in combating the disease.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/human-papillomavirus-vaccine-hpv-market
Moreover, the major players in the market are going for mergers and acquisitions for new product launches to further contribute to the market growth. For instance, in June 2020, on the eve of the Global Vaccine Summit 2020, vaccine manufacturers Merck & Co. inc., GlaxoSmithKline PLC, Innovax Pharmaceutical Ltd., and Serum Institute of India Pvt. Ltd., ramped up human papillomavirus vaccine (HPV) supply availability for Gavi-supported countries, which have amongst the highest cervical cancer burdens globally.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Type
- By Indication
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape – including,., Merck & Co. inc., GlaxoSmithKline PLC, Innovax Pharmaceutical Ltd., Serum Institute of India Pvt. Ltd., AstraZeneca PLC, and Johnson & Johnson Services, Inc., among others
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Human Papillomavirus Vaccine Market Report Segment
By Type
- Bivalent
- Quadrivalent
- Nonavalent
By Indication
- Cervical Cancer
- Anal Cancer
- Penile Cancer
- Vaginal Cancer
- Oropharyngeal Cancer
- Genital Warts
- Others
A full report of Human Papillomavirus Vaccine (HPV) Market is available at: https://www.omrglobal.com/industry-reports/human-papillomavirus-vaccine-hpv-market
Human Papillomavirus Vaccine (HPV) Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- A-S Medical Solutions LLC
- AstraZeneca PLC
- Bavarian Nordic A/S
- Bharat Biotech Ltd.
- GlaxoSmithKline PLC
- Innovax Pharmaceutical LLP
- Inovio Pharmaceuticals Inc.
- Johnson & Johnson Services Ltd.
- Merck & Co. Inc.
- Sanofi SA
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
